Lophos Holdings Inc.

About Lophos Holdings Inc.

Lophos Pharmaceuticals is a bioscience company focused on peyote research, cultivation, and drug development. They aim to provide safe access to plant-based therapeutics, support traditional use of psychedelic medicines, and develop new pharmacological treatments for disorders that may benefit from psychedelic-based therapies.

Products & Services

Ethically sourced and sustainably cultivated peyote - To conserve the endangered natural habitat of the plant.

Safe and compliant peyote cacti - Cultivated for regions worldwide where growth and consumption are legally permitted, including Canada.

Sustainable and natural psychedelic - Supplied as an alternative for patients seeking non-traditional treatments.

Specialties

Peyote research and cultivation Drug development for mental and physical health Plant-based psychedelic therapeutics Mescaline research through Lophos Laboratories

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Securities Purchase Agreement T: - FT: Securities Purchase Agreement	A: 127500 MR: - FA: $127,500 FAN: 127500	D: 2024-04-15 FD: 2024-04-15	1 investors

Securities Purchase Agreement Latest

2024-04-15

$128K

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Claire Stawnyczy

President | Chief Executive Officer | Director

R

Remantra Sheopaul

Chief Financial Officer

G

Giselle Barona

Quality Person in Charge (QPIC)

E

Evan Stawnyczy

Director | Advisor | Technology, Security, and Indigenous Affairs

J

John Karagiannidis

Director

J

Jeremy Pestun

Director

View 5 more team members with Pro

Unlock Full Team Directory

Recent News